PipelinePharma Logo
PipelinePharma Logo

CTD Dossier Marketplace

Direct connection with CTD dossier (IP) owners and manufacturers

Marketing Authorizations Database

Search across marketing authorization registers
Sign in Get started

Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-209 manufacturers

Filters

None products found

pp-209

Solution for infusion

Dossier type
US CTD
Dossier status
Under development
Country of origin
United States
GMP approvals
FDA
Comments
Indication: Acute ischaemic stroke (AIS) in patients with large vessel occlusion (LVO) undergoing endovascular thrombectomy (EVT) Clinical stage: Phase 2 Modality: Biological (novel Smart Growth Factor™ — modified IGF-1 fusion protein — NBE) Mechanism / Target: Proprietary Smart Growth Factor™ platform; modified IGF-1 protein engineered to selectively bind and deliver IGF-1 to injured/ischaemic neurons via targeted delivery mechanism; promotes neuroprotection and neuroregeneration in the stroke penumbra; selectively delivered to injured cells, avoiding systemic IGF-1 effects Route / form: IV infusion (administered up to 24 hours post-stroke onset) Differentiation: First targeted neuroprotectant in Phase 2 for ischaemic stroke; selectively delivers IGF-1 to injured neural cells — avoids systemic hypoglycaemia;
Manufacturer #39346
Clinical-stage company developing Rx precision growth factor fusion protein therapies using its Smart Growth Factor™ platform for accurate IGF1 delivery to injury sites. Lead injectable candidate scp776 is advancing in a Phase 2 stroke recovery trial. Focused on serious acute neurological conditions with significant unmet medical need.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.